Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muneyuki Sakata

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Annals of Nuclear Medicine|December 1, 2006
A feasibility study of [11C]SA4503-PET for evaluating sigmal receptor occupancy by neuroleptics: the binding of haloperidol to sigma1 and dopamine D2-like receptorsKiichi Ishiwata, Kenji Oda, Muneyuki Sakata, et al.
Frontiers in Aging Neuroscience|May 6, 2022
Possibility of Enlargement in Left Medial Temporal Areas Against Cerebral Amyloid Deposition Observed During Preclinical StageEtsuko Imabayashi, Kenji Ishii, Jun Toyohara, et al.
Annals of Nuclear Medicine|August 9, 2021
First clinical assessment of [<sup>18</sup>F]MC225, a novel fluorine-18 labelled PET tracer for measuring functional P-glycoprotein at the blood-brain barrierJun Toyohara, Muneyuki Sakata, Kenji Ishibashi, et al.
EJNMMI Physics|April 22, 2024
Phantom and clinical evaluation of the Bayesian penalised likelihood reconstruction algorithm Q.Clear without PSF correction in amyloid PET imagesKei Wagatsuma, Muneyuki Sakata, Kenta Miwa, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 11, 2017
Initial Evaluation of an Adenosine A<sub>2A</sub> Receptor Ligand, <sup>11</sup>C-Preladenant, in Healthy Human SubjectsMuneyuki Sakata, Kenji Ishibashi, Masamichi Imai, et al.
Journal of Alzheimer'S Disease : JAD|November 28, 2019
Metabolic Network Topology of Alzheimer's Disease and Dementia with Lewy Bodies Generated Using Fluorodeoxyglucose Positron Emission TomographyMasamichi Imai, Mika Tanaka, Muneyuki Sakata, et al.
Geriatrics & Gerontology International|February 12, 2017
The neural substrate of gait and executive function relationship in elderly women: A PET studyRyota Sakurai, Kenji Ishii, Masashi Yasunaga, et al.
Biological Psychiatry|July 31, 2007
High occupancy of sigma-1 receptors in the human brain after single oral administration of fluvoxamine: a positron emission tomography study using [11C]SA4503Masatomo Ishikawa, Kiichi Ishiwata, Kenji Ishii, et al.
Geriatrics & Gerontology International|July 2, 2010
Development of PET radiopharmaceuticals and their clinical applications at the Positron Medical CenterKiichi Ishiwata, Yuichi Kimura, Keiichi Oda, et al.
Global Health & Medicine|January 1, 2025
Patient-specific brain fluorodeoxyglucose positron emission tomography can detect the first effects of combination antiretroviral therapy in patient with HIV infectionMiyako M Chikanishi, Junko Tanuma, Kenji Ishii, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Annals of Nuclear Medicine|December 1, 2006
A feasibility study of [11C]SA4503-PET for evaluating sigmal receptor occupancy by neuroleptics: the binding of haloperidol to sigma1 and dopamine D2-like receptorsKiichi Ishiwata, Kenji Oda, Muneyuki Sakata, et al.
Frontiers in Aging Neuroscience|May 6, 2022
Possibility of Enlargement in Left Medial Temporal Areas Against Cerebral Amyloid Deposition Observed During Preclinical StageEtsuko Imabayashi, Kenji Ishii, Jun Toyohara, et al.
Annals of Nuclear Medicine|August 9, 2021
First clinical assessment of [<sup>18</sup>F]MC225, a novel fluorine-18 labelled PET tracer for measuring functional P-glycoprotein at the blood-brain barrierJun Toyohara, Muneyuki Sakata, Kenji Ishibashi, et al.
EJNMMI Physics|April 22, 2024
Phantom and clinical evaluation of the Bayesian penalised likelihood reconstruction algorithm Q.Clear without PSF correction in amyloid PET imagesKei Wagatsuma, Muneyuki Sakata, Kenta Miwa, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 11, 2017
Initial Evaluation of an Adenosine A<sub>2A</sub> Receptor Ligand, <sup>11</sup>C-Preladenant, in Healthy Human SubjectsMuneyuki Sakata, Kenji Ishibashi, Masamichi Imai, et al.
Journal of Alzheimer'S Disease : JAD|November 28, 2019
Metabolic Network Topology of Alzheimer's Disease and Dementia with Lewy Bodies Generated Using Fluorodeoxyglucose Positron Emission TomographyMasamichi Imai, Mika Tanaka, Muneyuki Sakata, et al.
Geriatrics & Gerontology International|February 12, 2017
The neural substrate of gait and executive function relationship in elderly women: A PET studyRyota Sakurai, Kenji Ishii, Masashi Yasunaga, et al.
Biological Psychiatry|July 31, 2007
High occupancy of sigma-1 receptors in the human brain after single oral administration of fluvoxamine: a positron emission tomography study using [11C]SA4503Masatomo Ishikawa, Kiichi Ishiwata, Kenji Ishii, et al.
Geriatrics & Gerontology International|July 2, 2010
Development of PET radiopharmaceuticals and their clinical applications at the Positron Medical CenterKiichi Ishiwata, Yuichi Kimura, Keiichi Oda, et al.
Global Health & Medicine|January 1, 2025
Patient-specific brain fluorodeoxyglucose positron emission tomography can detect the first effects of combination antiretroviral therapy in patient with HIV infectionMiyako M Chikanishi, Junko Tanuma, Kenji Ishii, et al.
Pageof 7